Tengjun Biotechnology Corp. Increase (Decrease) in Inventories
Tengjun Biotechnology Corp. reported Increase (Decrease) in Inventories of $1.35 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2023-08-15
- Tengjun Biotechnology Corp. increase (decrease) in inventories for the quarter ending 2023-06-30 was $1.30M.
- Tengjun Biotechnology Corp. increase (decrease) in inventories for the quarter ending 2023-03-31 was $50.11K.
- Tengjun Biotechnology Corp. increase (decrease) in inventories for the quarter ending 2022-12-31 was -$355.86K, a 743.31% decline year-over-year.
- Tengjun Biotechnology Corp. increase (decrease) in inventories for the quarter ending 2022-09-30 was $236.06K.
- Tengjun Biotechnology Corp. increase (decrease) in inventories for fiscal 2022 was -$1.85M, a 949.50% decline from fiscal 2021.
- Tengjun Biotechnology Corp. increase (decrease) in inventories for fiscal 2021 was $217.53K, a 30.54% decline from fiscal 2020.
- Tengjun Biotechnology Corp. increase (decrease) in inventories for fiscal 2020 was $313.20K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-15 | $1.35M 10-Q · filed 2023-08-15 | $991.25K derived: sum of 3 quarters · filed 2023-08-15 | $1.23M derived: sum of 4 quarters · filed 2023-08-15 |
| 2023-03-31 | $50.11K 10-Q · filed 2023-05-15 | -$305.75K derived: sum of 2 quarters · filed 2023-05-15 | -$69.69K derived: sum of 3 quarters · filed 2023-05-15 | -$1.54M derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-12-31 | -$355.86K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$119.79K derived: sum of 2 quarters · filed 2023-04-17 | -$1.59M derived: sum of 3 quarters · filed 2023-08-15 | -$1.85M 10-K · filed 2023-04-17 |
| 2022-09-30 | $236.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.23M derived: sum of 2 quarters · filed 2023-08-15 | -$1.49M 10-Q · filed 2022-11-14 | -$1.44M derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-15 | -$1.73M 10-Q · filed 2023-08-15 | -$1.67M derived: sum of 3 quarters · filed 2023-08-15 | |
| 2022-03-31 | -$258.84K 10-Q · filed 2023-05-15 | -$203.52K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $55.32K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $217.53K 10-K · filed 2023-04-17 | ||
| 2021-09-30 | $162.22K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $313.20K 10-K · filed 2022-03-31 |